Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer.
about
Improving radiotherapy quality assurance in clinical trials: assessment of target volume delineation of the pre-accrual benchmark case.Dosimetric uncertainties of three-dimensional dose reconstruction from two-dimensional data in a multi-institutional study.Continuous maximum flow segmentation method for nanoparticle interaction analysis.Variability of target and normal structure delineation for breast cancer radiotherapy: an RTOG Multi-Institutional and Multiobserver StudyProspective randomized double-blind pilot study of site-specific consensus atlas implementation for rectal cancer target volume delineation in the cooperative group setting.Delineation in thoracic oncology: a prospective study of the effect of training on contour variability and dosimetric consequencesInterobserver delineation variation in lung tumour stereotactic body radiotherapy.Is a Clinical Target Volume (CTV) Necessary in the Treatment of Lung Cancer in the Modern Era Combining 4-D Imaging and Image-guided Radiotherapy (IGRT)?Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma - benchmark for a prospective multi-institutional study.Impact of PET - CT motion correction in minimizing the gross tumor volume in non-small cell lung cancerLung dose analysis in loco-regional hypofractionated radiotherapy of breast cancerA semiautomatic CT-based ensemble segmentation of lung tumors: comparison with oncologists' delineations and with the surgical specimenVariations in CT determination of target volume with active breath co-ordinate in radiotherapy for post-operative gastric cancer.Uncertainties in target volume delineation in radiotherapy - are they relevant and what can we do about them?Conformal radiotherapy for lung cancer: interobservers' variability in the definition of gross tumor volume between radiologists and radiotherapistsPET and PET-CT in radiation treatment planning for lung cancer.Critical discussion of evaluation parameters for inter-observer variability in target definition for radiation therapy.Implementation of diffusion-weighted magnetic resonance imaging in target delineation of central lung cancer accompanied with atelectasis in precision radiotherapyComparison of intensity-modulated radiotherapy planning based on manual and automatically generated contours using deformable image registration in four-dimensional computed tomography of lung cancer patientsTarget volume delineation and margins in the management of lung cancers in the era of image guided radiation therapy.A region growing method for tumor volume segmentation on PET images for rectal and anal cancer patients.Suboptimal use of intravenous contrast during radiotherapy planning in the UK.The management of respiratory motion in radiation oncology report of AAPM Task Group 76.Variabilities of Magnetic Resonance Imaging-, Computed Tomography-, and Positron Emission Tomography-Computed Tomography-Based Tumor and Lymph Node Delineations for Lung Cancer Radiation Therapy Planning.Optimizing localization accuracy in head and neck, and brain radiotherapy.Early clinical evaluation of a novel three-dimensional structure delineation software tool (SCULPTER) for radiotherapy treatment planning.Novel multimodality segmentation using level sets and Jensen-Rényi divergence.Impact of FDG-PET on lung cancer delineation for radiotherapy.Effect of contrast enhanced CT scans on heterogeneity corrected dose computations in the lung.Assessment of consistency in contouring of normal-tissue anatomic structures.A teaching intervention in a contouring dummy run improved target volume delineation in locally advanced non-small cell lung cancer: Reducing the interobserver variability in multicentre clinical studies.Geometrical differences in target volumes between slow CT and 4D CT imaging in stereotactic body radiotherapy for lung tumors in the upper and middle lobe.
P2860
Q27690859-7AA0D62E-1CAB-42E2-B175-DD4BF8BBAD12Q30983842-77CC0A32-7CD7-4935-B15C-925A19C72888Q33943602-29C58DD1-4A7E-48BD-B4C7-07A0324694E8Q34027112-C1DF6B52-67E5-4F93-9915-680DDB24816DQ34088596-9068687E-CA88-4904-ADDA-CE6608A688E8Q35364985-0CBA8F90-7BA1-42A5-8C12-22CAA7FBA9BDQ36365506-C4619910-8749-4D1A-BE80-BC4E646A94EDQ36609568-319EE01F-E436-48B7-BAC9-8BD77E8164C3Q36843349-62F5F0D6-C66F-4F38-86AD-43F965925E24Q37052259-0CBDC4A9-F097-4343-A1E0-7E49A2E4B532Q37061962-9535059B-0B43-4410-BC3E-C6356092349AQ37111842-B8D63B57-0020-4E90-9FC1-A96DBC254D72Q37175592-0D14BE21-8A26-4429-B59F-F6C72405203FQ37258706-A3CD940E-565A-4436-90F1-592C1826CD62Q37321343-0BDD9D5E-77BF-4A81-8690-6281A07D4477Q37732292-53FDACB8-F9D0-4BC3-9B27-1B5BF08A61DEQ37979128-2E722107-E2D6-498F-B85F-6906D5832C2DQ41614749-EC19B5A4-2994-4551-B0A5-70E6416C7B9CQ42117833-01F4A8EF-F170-4B2C-9AEC-7A8425010E40Q42286681-9280C42A-43B4-4606-8F76-A7CF78CDA528Q43238161-F26F27CA-1E95-489A-9BFD-4C39D3FA0767Q43869716-20E78445-9CA6-4298-BDB5-5DA8B8D5E96BQ44924583-09C483F3-04F2-401C-820F-E7785C58B34CQ45065502-F7BFAEEE-AF89-45BC-9134-CC7D7B09288CQ48565944-7421FB4D-22DE-4933-B59A-CD7369A7CDC6Q50640318-2E24668B-EDB0-4D86-AA1E-DA0D47E64A52Q51134916-DDF5157B-FEC8-45FF-9BF0-92D8B6DCD684Q51382727-4EAB223C-AF2B-478E-AA2E-FB89B88AF7A0Q51626488-07569EB3-D6B5-4836-ABCD-C16678B295D5Q52947670-DB80FA50-9E4E-4DBE-9394-B313119B1BA9Q53165187-3F98B189-2474-40AA-A7C8-754036A52344Q53391674-9631F566-4F72-4D1E-8CD8-5B96EED9BE2F
P2860
Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Evaluation of a target contour ...... in non-small cell lung cancer.
@ast
Evaluation of a target contour ...... in non-small cell lung cancer.
@en
type
label
Evaluation of a target contour ...... in non-small cell lung cancer.
@ast
Evaluation of a target contour ...... in non-small cell lung cancer.
@en
prefLabel
Evaluation of a target contour ...... in non-small cell lung cancer.
@ast
Evaluation of a target contour ...... in non-small cell lung cancer.
@en
P2093
P1476
Evaluation of a target contour ...... in non-small cell lung cancer.
@en
P2093
Lagerwaard FJ
van Sörnsen de Koste J
P304
P356
10.1016/S0167-8140(99)00143-7
P577
1999-12-01T00:00:00Z